Industry news

The Analytics Revolution of 2018: Transforming Insights to Action in the Life Sciences Industry

Scott Beauchamp / Pharmaceutical Executive

The life sciences industry is undergoing a transformative shift. Under the new paradigm, patients are seeking greater transparency, physicians are losing prescribing autonomy, hospital consolidation is growing, and value-based medicine is paramount. This new reality demands a complete re-imagination of commercial strategies.

Russian authorities will subsidize execution of drug circulation monitoring system

GMP News

On February 23, 2018, the Russian Prime Minister signed a decree on the procedure for subsidizing implementation of a system to monitor the circulation of drugs for human use.

New artificial kidney gives patient freedom

Marchmont Innovation News

Scientists at the Moscow-based National Research University of Electronic Technology (MIET) have developed and tested a new device to function as an artificial kidney. It is portable and enables the patient to move around freely enough. 

Russian government's latest moves on drug labeling and pricing policy

Remedium

The Russian government plans to start investigation of the activities of some leading domestic and global drugmakers operating in the local market, due to their activities for the prevention of introducing a system of drug labeling in the country, according to recent statements by Russia’s Deputy Prime Minister Igor Shuvalov, reports The Pharma Letter’s Russia correspondent.

Russian government plans on innovative drugs and centralized mechanism for their purchase

Ремедиум

The Russian Federal Anti-Monopoly Service (FAS) has announced its plans to submit a proposal to the national government to speed up state registration of innovative drugs and to create a centralized mechanism for their purchase in the country, according to an official spokesman of head of FAS Sergey Artemyev, reports The Pharma Letter’s local correspondent.

Ferring to Invest in New Biotech Center

BioPharm International

Ferring Pharmaceuticals, a biopharmaceutical company specializing in reproductive medicine, announced on Feb. 14, 2018 that it is making a CHF 30-million (US$32 million ) investment in a new biotech center to expand its capabilities in biologics

26 February 2018

Clearside Biomedical Announces Organizational Changes Designed to Support Transition to a Commercial-Stage Company

Clearside Biomedical, Inc.  (NASDAQ:CLSD), a late-stage biopharmaceutical company developing first-in-class drug therapies to treat back-of-the-eye diseases, today announced the appointments of William (“Bill”) Humphries as the new Chairman of the Board and  Brion Raymond as Chief Commercial Officer.  These appointments are intended to further prepare the company for the potential commercialization of CLS-TA for suprachoroidal administration (“suprachoroidal CLS-TA”), its proprietary suspension formulation of the corticosteroid triamcinolone acetonide for the treatment of macular edema associated with non-infectious uveitis. 

This is a can't-miss event! Save 15% with promo code FPMF2018 Marketing Mixed feelings? Havas tackles the emotional motivations behind healthcare decisions with new agency

Beth Snyder Bulik / FiercePharma

Emotion is a strong decision driver, particularly in healthcare. It's so important, in fact, that Havas Health & You has launched an entire agency to focus on it. Using advanced algorithms and analysis, the new Havas Health Plus aims to understand and address the emotional triggers—what makes people do or choose something—to build better user experiences and creative communications.

AMRI expands its container closure integrity testing services into EU

GMP News

AMRI, a global contract research, development and manufacturing organization working with the life sciences industry to improve patient outcomes and quality of life, announced expansion of its industry-leading container closure integrity testing (CCIT) services into the European Union.

Korea pools patient data to enable digital health schemes

Nick Paul Taylor / FierceBiotech

South Korea is consolidating hospital medical data into a single 10 million-patient repository. The goal is to use Korea’s established medical IT system to build a resource that supports digital health initiatives and the development of new drugs and devices.